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The Dilemma of ImagingY. Chandrashekhar, MD,* Jagat Narula, MD, PHDyNot everything that can be counted counts, and
not everything that counts can be counted.
—Attributed to Albert Einstein (1)T raditionally, many diseases have beendeﬁned by their morphology and what bettertechnique is there to demonstrate mor-
phology in the living individual than imaging?
Some diseases such as hypertrophic cardiomyopathy
(HCM) started with a morphological sine qua non
(2), with ﬁrm data about other aspects of their natural
history coming much later. Many other morphological
signatures of cardiac diseases are following a similar
trajectory, especially with the widespread availability
of sophisticated imaging. One such condition is left
ventricular noncompaction (LV-NC)—a diagnosis
primarily based on morphology—and unlike HCM,
therein may lay a cautionary tale.
Imaging is a powerful technology, and with great
power comes great responsibility and the need to
use it wisely. The ability to see more and measure
more does not necessarily increase one’s ability to
diagnose better or label pathology that has a good
reason for needing a label. One has to only look at
the coevolution of the availability of 2-dimensional
(2D) echocardiography and mitral valve prolapse to
understand how we can go astray; the advent of
M mode and then 2D echocardiography created an
epidemic of mitral valve prolapse (MVP) in young
women, and the prevalence of MVP reached alarm-
ing proportions—many were labeled with pathology,
and many symptoms, both serious as well as trivial,
were immediately attributed to it (3). The frequencyFrom the *University of Minnesota and VA Medical Center, Minneapolis,
Minnesota; and the yIcahn School of Medicine at Mount Sinai, New York,
New York. The authors have reported that they have no relationships
relevant to the contents of this paper to disclose.of this diagnosis magically abated once we better
understood the saddle shape of the mitral valve and
the importance of limiting our diagnosis to MVP
found only on imaging in the correct plane. History
is possibly repeating itself, and we are perhaps
entering a similar phase with the diagnosis of
LV-NC!
In this issue of iJACC, a group of investigators
from Brussels (4) evaluated the prognostic import of
the 2 traditional cardiac magnetic resonance criteria
for LV-NC (noncompacted [NC] segment/compacted
[C] length in the long axis and NC/C mass in the
short axis, respectively) in 162 patients with classic
dilated cardiomyopathy (DCM) and 48 healthy con-
trols. Of the control subjects, 17% had morphology
consistent with hypertrabeculation, whereas 37%
and 45% of DCM patients met the NC/C length and
NC/C mass criteria, respectively, for LV-NC; 27%
fulﬁlled both criteria. Most importantly, however,
LV-NC deﬁned this way did not impact cardiac out-
comes. This once again illustrates the dilemma
among evangelists in the imaging community, that
is, the trouble with deﬁning disease based solely on
seeing more. Better imaging of morphology may
show too many variations from normal that may not
need deﬁning. In fact, even the 2 methods, thought
to be fairly accepted parameters for diagnosing LV-
NC, signiﬁcantly differed in their ability to classify
patients into high or low degree of LV-NC. Lacking
a gold standard, normal trabeculation may blend
into hypertrabeculation and then bleed into a non-
compacted cardiomyopathy without appropriate
milestone markers to identify this transition. What
needs a label and what remains a curiosity that does
not need identiﬁcation will thus remain a challenge
until we have more studies that establish a core set
of diagnostic criteria that can then be married to
imaging.
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991The other reason to publish this study is our
declared commitment (5) to highlight the importance
of negative ﬁndings, something that has been sorely
lacking in the literature, possibly to our detriment in
seeking the truth. There has been a deluge of papers
about LV-NC, and this morphology was soon
described across the spectrum in many different
subsets of pathology. Indeed, LV hypertrabeculation
has been described in the general population and
similar to the current study in DCM, without much
detriment. Like any new and controversial condition,
reports portending the bad overpopulate the litera-
ture early on, more often than those reports that are
more measured about it, and a similar phenomenon
seems to have occurred with LV-NC. This report,
pointing toward the possibly less ominous nature of
trabeculations in the failing heart, might serve to
temper our enthusiasm to prematurely place a pa-
thology label without letting the froth settle down.
Of course, this is not the ﬁnal word. The investigators
excluded subjects with neuromuscular disease, a
group thought to have a richer association with
LV-NC. This study, therefore, does not exclude the
classic LV-NC syndrome with more sinister out-
comes, nor does it exclude the fact that our deﬁnition
of LV-NC based solely on morphology might be
deﬁcient. Nevertheless, that tried and trusted
parameters for prognosis in DCM such as volumes
and ejection fraction predicted outcomes in this
reasonable-sized study, whereas the more exotic
parameters such as NC/C ratio did not, is also reas-
suring that imaging morphology is useful; it is just
that in our excitement to describe more things on
imaging, we should not get carried away with new
nomenclature until robust data show the usefulness
of our descriptors. Imaging is under scrutiny for
excess of use and possible misuse. This would be one
way to avoid sowing confusion with a plethora of
descriptive traits that are not matched by a uniqueassociation with proven disease and with clear
prognostic signiﬁcance. Even if we cannot decide on
the prognostic aspects of hypertrabeculation, imag-
ing may yet allow us to question and then hopefully
ﬁnd an answer as to what does it all mean. Hyper-
trabeculation remains fascinating. What is the gene-
sis of hypertrabeculation in DCM, which was more
common than in normal subjects in this study? Is it
that a pathology such as DCM affects the compacted
segment more than the trabeculated segments, and
does the increased ratio of NC/C represent thinning
of the compacted segment rather than an increased
trabeculation per se. In the extreme, is it even
possibly some form of reversion to a fetal mor-
phology phenotype, à la reversion of genetic pro-
gramming to fetal phenotype in the failing heart. It
would be interesting to know what the stimuli are if
it is growth of trabeculae rather than thinning of the
compacted wall, and why does wall stress not affect
both similarly. It is interesting that patients in this
study with a lower NC/C mass (<31%) had more sys-
tolic hypertension, thicker LV walls, and a larger LV
mass index.
Imaging is revealing more and more details, but
having an “oil immersion” view is not always useful
over conventional imaging. The wisdom in imaging is
beyond the image itself—it is in understanding what
an image means to the patient and his treatment and
in separating the signal from the noise. Hopefully,
iJACC can continue to be your partner in ﬁguring out
this important detail. Please write to us about what
you think about LV-NC and if it is a real disease or just
a passing fad! Would genetics be the only determi-
nant of truthfully imaged morphology?
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